The CYP11B2 -344C/T variant was associated with better antihypertensive response to amlodipine, but not with essential hypertension in Jordanians.
Is the CYP11B2 -344C/T variant associated with essential hypertension and amlodipine response in Jordanians?
The CYP11B2 -344C/T variant may serve as a pharmacogenetic marker for amlodipine response in Jordanian patients with essential hypertension.
Absolute Event Rate: 0% vs 0%
The CYP11B2 -344C/T variant was not associated with EH in Jordanians, but it was associated with amlodipine response. Further studies with larger sample size are needed to validate these findings.
Abdelrazaq et al. (Fri,) reported a other. The CYP11B2 -344C/T variant was associated with better antihypertensive response to amlodipine, but not with essential hypertension in Jordanians.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: